Search

everythinglearnresearchcommunity

for

Search:↓

A pet ferret had a serious infection from Mycobacterium xenopi, which can spread to humans.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

The conclusion is that high-potency steroids or tacrolimus are effective treatments for erosive pustular dermatosis of the scalp.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Nuclear shape and chromatin changes affect gene expression in skin cell differentiation.

Azithromycin can rarely cause a severe drop in white blood cells.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

The 16-year-old girl with hair loss was successfully treated for alopecia areata, leading to significant hair regrowth.

Alopecia mucinosa on the face can be linked to mycosis fungoides, a type of lymphoma.

Micrografts improve hair density and thickness without side effects.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

Different parts of the body's fat tissue have unique cell types and characteristics, which could help treat chronic wounds.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Melatonin may help reduce the needed dose of prednisolone and improve hair growth in alopecia areata patients.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Transplanted hair follicles can change and adapt to new areas of the body, with the immune system possibly playing a role in this adjustment.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Ruxolitinib can cause a delayed skin reaction on the nose.